Form 4: IRIX CFO Romeo Dizon Buys 1,125 Shares at ~$1.32–$1.39
Rhea-AI Filing Summary
Iridex Corp (IRIX) Form 4: Romeo R. Dizon, identified as the Chief Financial Officer, reported three transactions on 09/04/2025. The filing shows acquisitions of 404, 96, and 625 common shares at prices of $1.32, $1.345, and $1.39 respectively. After those transactions the filing lists beneficial ownership totals of 54,029, 54,125, and 54,750 shares. The form was signed by an attorney-in-fact on 09/05/2025.
Positive
- Insider purchases disclosed: The CFO reported acquisitions totaling 1,125 shares on 09/04/2025, increasing beneficial ownership to 54,750 shares.
- Timely reporting and signature: The Form 4 includes an attorney-in-fact signature dated 09/05/2025, indicating the filing was executed.
Negative
- None.
Insights
TL;DR: CFO made three small purchases on 09/04/2025, modestly increasing reported beneficial ownership.
The reported transactions consist of three acquisitions totaling 1,125 common shares executed at incremental prices of $1.32, $1.345, and $1.39. Reported post-transaction beneficial ownership figures rise from 54,029 to 54,750 shares. These are routine insider purchases disclosed on Form 4 and, standing alone, do not provide performance metrics or change in company fundamentals in the filing.
TL;DR: Disclosed insider purchases are properly reported and signed by an attorney-in-fact; filing shows compliance with Section 16 reporting.
The Form 4 lists the reporter as CFO and includes an attorney-in-fact signature dated 09/05/2025. All three transactions are dated 09/04/2025 and specify share counts and prices. The filing contains no amendments, derivative transactions, or explanatory footnotes beyond the signature block.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Purchase | Common Stock | 404 | $1.32 | $533.28 |
| Purchase | Common Stock | 96 | $1.345 | $129.12 |
| Purchase | Common Stock | 625 | $1.39 | $868.75 |